Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank of Montreal (BMO) vs Inovio Pharmaceuticals Inc (INO) Price & Performance

Bank of MontrealTrade
Inovio Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Bank of Montreal vs Inovio Pharmaceuticals Inc — how do they compare? Bank of Montreal trades at $182.04 (market cap $126.83B), while Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M). The key difference: Bank of Montreal is far larger — about 1614.6× Inovio Pharmaceuticals Inc's market cap, and Bank of Montreal pays a 2.69% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

BMOINO
Market Cap
$126.83B$78.55M
Sector
FinancialsHealth
52-Week High
$183.65$2.87
52-Week Low
$112.54$0.66
Dividend Yield
2.69%
Enterprise Value
$49.56M

Returns comparison

Trailing returns across standard periods

About Bank of Montreal

Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.

Read more on BMO

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO